Quantum Biopharma (QNTM) Other Non Operating Income (2019 - 2026)
Quantum Biopharma (QNTM) posted Other Non Operating Income of $892057.0 for Q1 2026, up 8029.4% sequentially from -$11250.0 in Q3 2025, and up 206.26% YoY from $291272.0 in Q1 2025.
Quantum Biopharma (QNTM) Other Non Operating Income (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Other Non Operating Income for 8 years, with the latest figure at $892057.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 206.26% year-over-year to $892057.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 280.86% YoY) and the FY2024 annual result came in at $57743.0, changed N/A from the prior year.
- Other Non Operating Income advanced to $892057.0 in Q1 2026 per QNTM's latest filing, from -$11250.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $892057.0 in Q1 2026 and troughed at -$37139.0 in Q3 2022.
- A 5-year average of $146022.6 and a median of $57743.0 in 2024 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income tumbled 253.39% in 2024, then soared 1566.7% in 2025.
- Over 5 years, Other Non Operating Income stood at -$37139.0 in 2022, then soared by 121.63% to $8032.0 in 2023, then soared by 618.91% to $57743.0 in 2024, then tumbled by 119.48% to -$11250.0 in 2025, then surged by 8029.4% to $892057.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $892057.0, -$11250.0, and $110267.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 892,057.00 |
| Sep 30, 2025 | -11,250.00 |
| Jun 30, 2025 | 110,267.00 |
| Mar 31, 2025 | 291,272.00 |
| Dec 31, 2024 | 57,743.00 |
| Sep 30, 2024 | -12,320.00 |
| Mar 31, 2024 | 17,476.00 |
| Sep 30, 2023 | 8,032.00 |
| Mar 31, 2023 | 206,950.00 |
| Sep 30, 2022 | -37,139.00 |
| Mar 31, 2022 | 83,161.00 |
| Jun 30, 2021 | 3.02 Mn |
| Sep 30, 2020 | 5.16 Mn |
| Jun 30, 2020 | 262,575.93 |
| Mar 31, 2020 | 1.72 Mn |
| Sep 30, 2019 | 5.15 Mn |
| Jun 30, 2019 | 3.83 Mn |
| Mar 31, 2019 | 227,730.84 |